Acute coronary syndromes: Clinical characteristics, management, and outcomes at the American University of Beirut Medical Center, 2002-2005

Clinical Cardiology

Volumn 33, Issue 1, 2010, Pages

  Abdallah, Mouhammad ^a   Karrowni, Wassef ^a   Shamseddeen, Wael ^a   Itani, Salam ^a   Kobeissi, Loulou ^a   Ghazzal, Ziyad ^a   Alam, Samir ^a   Dakik, Habib A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FIBRIC ACID DERIVATIVE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NITRIC ACID DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE UTILIZATION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNIVERSITY HOSPITAL; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY, BALLOON; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; EVIDENCE-BASED PRACTICE; FEMALE; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEBANON; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 74949107543     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20636     Document Type: Article

References (15)

1. World Health Organization. World Health Report 2002: Reducing risks, promoting healthy life. Geneva: World Health Organization, 2002.
2. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol. 2008;51:210-247.
3. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2003;24:28-66.
4. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2007;50:652-676.
5. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and management of non-ST-segment elevation acute coronary syndromes. The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J. 2007;28:1598-1660.
6. The GRACE Investigators. GRACE (Global Registry of Acute Coronary Events): a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141:190-199.
7. Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome. Eur Heart J. 2002;23:1177-1189.
8. Fox KA, Steg PG, Eagle KA, et al; GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1996-2006. JAMA. 2007;297:1892-1900.
9. Fox KA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G. The ENACT study: a pan-European survey of acute coronary syndromes. Eur Heart J. 2000;21:1440-1449.
10. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999. The National Registry of Myocardial Infarction 1, 2, 3. J Am Coll Cardiol. 2000;36:2056-2063.
11. Ryan JW, Peterson ED, Chen AY, et al. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from CRUSADE. Circulation. 2005;112:3049-3057.
12. Bonow RO, Smaha LA, Smith SCJr, Mensah GA, Lenfant C. World heart day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation. 2002;106:1602-1605.
13. Antman E, Bassand JP, Klein W, et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959.
14. Dakik HA, Koubeissi Z, Kleiman NS, et al. Acute myocardial infarction: clinical characteristics, management, and outcome in a university medical center in a developing country. Can J Cardiol. 2004;20:789-793.
15. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). Lancet. 2004;364:937-952.